Zolmitriptan in the treatment of migraine attacks - The ARES study;Zolmitriptan in der migräne-anfallsbehandlung - Die ARES-studie

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 51-52, 2000, Pages 1984-1993

  Sturzenegger, M ^a   Daems, K ^a   Billeter, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Migraine; Triptans; Zolmitriptan

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PHOTOPHOBIA; RECURRENT DISEASE; SWITZERLAND; SYMPTOM; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; PAIN MEASUREMENT; RECURRENCE; TREATMENT OUTCOME; TRYPTAMINES;

EID: 0034707225     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Acute management of migraine: Triptans and beyond
2. New anti-migraine drugs: Present and beyond the millenium
3. Work and family impact of migraine: A population-based case-control study
4. The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers
5. 1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans
6. Effects of zolmitriptan on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine
7. 1D receptor agonist in the acute oral treatment of migraine: A double-blind, placebo-controlled, dose-range finding study
8. Genetics of primary headaches
9. Recent advances in functional neuroimaging
10. 1B/1D agonist for migraine
11. Lack of an effect of zolmitriptan on psychometric task performance: Results of a placebo-controlled study in healthy volunteers
12. 1B/1D receptor partial agonist for the acute treatment of migraine
13. 1B/1D agonist. International clinical experience based on >3000 subjects treated with zolmitriptan
14. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
15. The long-term tolerability and efficacy of oral zolmitriptan (Zomig 311C90) in the acute treatment of migraine: An international study
16. A multicenter, double-blind, placebo-controlled, dose-range finding study to investigate the efficacy and safety of oral doses of 311C90 in the acute treatment of migraine
17. Zolmitriptan
18. 1B/1D agonist: An overview of efficacy
19. Burden of migraine: Societal costs and therapeutic opportunities
20. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain